Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx IncfiledCriticalModernatx Inc
Publication of AR121205A1publicationCriticalpatent/AR121205A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La descripción se refiere a vacunas de ácido ribonucleico (ARN) contra el coronavirus, así como a métodos de uso de las vacunas y composiciones que comprenden las vacunas.The disclosure relates to ribonucleic acid (RNA) vaccines against coronavirus, as well as methods of using the vaccines and compositions comprising the vaccines.
ARP210100221A2020-01-282021-01-28
RNA VACCINES AGAINST CORONAVIRUS
AR121205A1
(en)
VIRUSES OF GENETICALLY MODIFIED VESICULAR STOMATITIS, IMMUNOGENIC COMPOSITION THAT UNDERSTANDS IT, METHOD TO PRODUCE IT, METHODS TO ADAPT A VIRUS TO GROW IN THE CULTURE CULTURE AND TO PROTECT A MAMMER AGAINST THE INFOGRAPH WITH AN ORGANIZATION
Vaccine composition comprising e. meleagrimitis 2 and meleagrimitis 1; use of said vaccine to immunize a turkey against cocciodiosis; method to identify an eimeria isolate as an eimeria meleagrimitis 2; and amplification kit by pcr.